sevoflurane has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
Excerpt | Relevance | Reference |
---|---|---|
"However, the effect of sevoflurane on head and neck squamous cell carcinoma (HNSCC) remains unclear." | 1.48 | Sevoflurane inhibits the malignant potential of head and neck squamous cell carcinoma via activating the hypoxia‑inducible factor-1α signaling pathway in vitro. ( Chen, Z; Hu, R; Jiang, H; Jiang, J; Lu, Y; Yan, J; Yang, Y, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yang, Y | 1 |
Hu, R | 1 |
Yan, J | 1 |
Chen, Z | 1 |
Lu, Y | 1 |
Jiang, J | 1 |
Jiang, H | 1 |
1 other study available for sevoflurane and Squamous Cell Carcinoma of Head and Neck
Article | Year |
---|---|
Sevoflurane inhibits the malignant potential of head and neck squamous cell carcinoma via activating the hypoxia‑inducible factor-1α signaling pathway in vitro.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Gene Expres | 2018 |